Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 9 - Compounds containing elements of the 5th group of the periodic system
Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
10/2009
10/28/2009CN101565433A New production technology of diethyl (tosyloxy)methylphosphonate
10/28/2009CN101565432A O,O-methyl-ethyl-thiophosphorylchloride, an important intermediate of organophosphorus insecticide
10/28/2009CN101565431A Process for synthetizing phosphoester oligopolymer BDP
10/28/2009CN101565412A Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
10/28/2009CN101565404A Heterocyclic compounds
10/28/2009CN101565177A Method for synchronously reclaiming orthophosphorous acid and glyphosate in glyphosate production wastewater by chemical precipitation method
10/28/2009CN100554274C Method for synthesizing adefovir dipivoxil ester
10/28/2009CN100554273C Derivative of organic phosphorus of containing structure of spirocyclic / cyclopropane, preparation method and application
10/28/2009CN100554272C Bis(hexamethylene triamine penta (methylene phosphonic acid)) and production process thereof
10/28/2009CN100554253C Process for synthesizing lacidipine of antihypertensive drugs
10/28/2009CN100553607C An aqueous dispersion containing pyrogenically prepared metal oxide particles and dispersants
10/27/2009US7609279 Data-driven layout engine
10/27/2009US7608713 Tertiary phosphines and their methods of preparation
10/27/2009US7608709 Such as (R,R)-2,3-bis(tert-butylmethylphosphino)quinoxaline, by deprotonating dialkylphosphine-borane, reacting with 2,3-dihalogenopyrazine, then deboranating; storage stability; hydrogenation catalysts
10/27/2009US7608613 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability
10/27/2009US7608603 preferential enzyme inhibitors comprising fused pyrazolo pyrimidine derivatives used for treating arthritis, Crohns disease, irritable bowel syndrome, adult respiratory distress syndrome, or chronic obstructive pulmonary disease
10/27/2009CA2361174C 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
10/22/2009WO2009128631A2 Method for preparing racemic or optically active α-glycerophosphorylcholine and derivative thereof
10/22/2009WO2009128348A1 Phenylphosphorylcholine derivatives
10/22/2009WO2008055964A8 Method for producing cyclic phosphines or biphosphines, cyclic phosphonates of optically active diols, and the production of same
10/22/2009US20090264609 Single site catalyst systems having a scorpion-like structure
10/22/2009US20090264339 Heterocyclic Compounds
10/22/2009US20090263621 Porous organic-inorganic hybrid materials and adsorbent comprising the same
10/22/2009US20090261300 Heteroacene derivative, tetrahaloterphenyl derivative, and processes for producing the same
10/22/2009CA2721371A1 Small molecule inhibitors of the pleckstrin homology domain and methods for using same
10/21/2009EP1710247B1 Transition metal compound and catalyst for olefin polymerization
10/21/2009EP1567478B1 Method of producing nitrile compounds from ethylenically-unsaturated compounds
10/21/2009EP1534427B1 An adamantyl catalyst system
10/21/2009EP1421139B1 Higher alkylated triaryl phosphate ester flame retardants
10/21/2009EP1383778B1 Agonists and antagonists of sphingosine-1-phosphate receptors
10/21/2009CN101563355A Polymer composition containing flame retardant and process for producing the same
10/21/2009CN101560227A Flame-retarding compound, flame-retardant prepared thereby and preparation method thereof
10/21/2009CN101560226A Novel phosphorus series compound as well as preparation method and application thereof
10/21/2009CN101560225A Preparation method of tetrakis hydroxymetyl phosphonium sulfuric-urea polymer
10/21/2009CN101560224A Hydrolysis process in process of preparing glyphosate by glycine method
10/21/2009CN101560223A Phosphoryl amino acid stilbene derivative, preparing method and application thereof
10/21/2009CN101560186A Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/21/2009CN101560172A Nitrone free radical probe derived from chiral amino acid and preparation method thereof
10/21/2009CN100551936C Process for the preparation of a metalloorganic compound comprising at least one imine ligand
10/21/2009CN100551928C M-crystal type of adefovir dipivoxil ester and preparation method and medicine application
10/21/2009CN100551927C Circulation recovery method for glyphosate mother liquid
10/20/2009US7605262 Podophyllotoxin derivatives
10/20/2009US7605175 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
10/20/2009US7605147 Acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same
10/20/2009CA2354705C Process for producing deoiled phosphatides
10/20/2009CA2301104C Process for the preparation of oxazaphosphorine-2-amines
10/20/2009CA2245066C Zinc-phthalocyanines and corresponding conjugates, their preparation and use in photodynamic therapy and as diagnostic agents
10/15/2009WO2009126174A1 Stable aqueous compositions comprising bioactive creatine species
10/15/2009WO2009125565A1 Ruthenium compound and method for producing optically active aminoalcohol compound
10/15/2009WO2009125366A1 Substituted 2-phenyl-pyridine derivatives
10/15/2009WO2009124897A1 Complex compound containing a metal atom and phosphine derivative as the ligand
10/15/2009WO2009124627A1 Fluorine derivatives for organic electroluminescence devices
10/15/2009WO2009053445A3 Polymorphic forms of ibandronate sodium and processes for preparation thereof
10/15/2009WO2009050372A3 Compositions containing lipophosphoramides and use thereof in gene therapy
10/15/2009US20090259073 Method for producing aldehyde using bisphosphite and group 8-10 metal compound, and such bisphosphite
10/15/2009US20090259068 Reaction systems for making n-(phosphonomethyl) glycine compounds
10/15/2009US20090259064 Synthesis of phosphonic acid labeled compounds
10/15/2009US20090259042 Electrochromic compounds
10/15/2009US20090258997 Novel phosphorus-containing compounds and their preparing process and use
10/15/2009US20090258840 Method and compositions for treating hematological malignancies
10/15/2009US20090258422 Optically detectable organophosphonates
10/15/2009US20090258146 Ink set, and ink jet recording method using the ink set
10/15/2009CA2719636A1 Substituted 2-phenyl-pyridine derivatives
10/14/2009EP1907402B1 Bisphosphines
10/14/2009EP1805107B1 Process for the preparation of highly purified, dialkyl phosphinic acids
10/14/2009EP1473297B1 Process for producing tertiary phosphine having bulky hydrocarbon group bonded
10/14/2009EP1390343B1 Novel retinoid derivatives and an anti-cancer pharmaceutical composition comprising said compounds
10/14/2009CN101555259A Phosphine oxazoline ligand of spiral ring skeleton, a synthetic method thereof and applications in asymmetric hydrogenation of various types of imine coumpounds and various types of non-functionalized
10/14/2009CN101555258A Method for synthesizing phosphamide compound
10/14/2009CN100549018C Phosphorylcholine group-containing compound and surface modifying agent composed of such compound
10/14/2009CN100548948C Ligands for metals and improved metal-catalyzed processes based thereon
10/13/2009US7601850 less hypercalcemic than 1a,25 dihydroxy vitamin D3; bone disorders, psoriasis
10/13/2009US7601848 Multifunctional reagent for the synthesis of thiol modified oligomers
10/13/2009US7601845 Optically detectable organophosphonates
10/13/2009US7601770 Adjust fluid flow; high strength; shrinkage inhibition; mixture of graft polymer; polyoxyalkylene glycol and organic phosphate
10/13/2009US7601719 Compounds, methods and pharmaceutical compositions for inhibiting PARP
10/13/2009US7601703 Complexing the target cell with therapeutic agent; antiproliferative agent
10/13/2009US7601424 Stabilized semiconductor nanocrystals
10/13/2009CA2292775C Cyanoguanidines as cell proliferation inhibitors
10/08/2009WO2009123191A1 Polysiloxane, acrylic compound, and vinyl compound
10/08/2009WO2009123016A1 Copper phosphonate compound, and infrared absorption material and laminate containing the copper phosphonate compound
10/08/2009WO2009121989A1 Method for obtaining polysubstituted pyrrolidines with hepatitis c inhibiting activity
10/08/2009WO2009121935A2 Pharmaceutical composition with bisphosphonate
10/08/2009WO2009121786A1 Process for the preparation of triamides from ammonia and amidodichlorides
10/08/2009WO2009121736A1 Unsaturated diphosphine monoxides
10/08/2009WO2009121347A1 Method for the stereoselective synthesis of phosphorus compounds
10/08/2009WO2009121245A1 Fostriecin derivatives and the pharmaceutical uses thereof
10/08/2009US20090253931 Process for the preparation of highly purified, dialkydithiophosphinic compounds
10/08/2009US20090253926 Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation
10/08/2009US20090253923 Preparation of glycerol derivatives ad intermediates therefor
10/08/2009US20090253914 Process for the preparation of onium salts with dialkylphosphate, dialkylphosphinate or (o-alkyl)alkyl- or alkylphosphonate anions having a low halide content
10/08/2009US20090253907 Cyclopentadienyl, indenyl or fluorenyl substituted phosphine compounds and their use in catalytic reactions
10/08/2009US20090253659 Cycloalkylidene Compounds As Modulators of Estrogen Receptor
10/08/2009US20090253658 Fat Accumulation Inhibitor
10/08/2009US20090253656 Bcrp/abcg2 inhibitor
10/08/2009US20090253655 Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
10/08/2009US20090253654 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment
10/08/2009US20090253653 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability
10/08/2009US20090253035 Non-aqueous electrolyte cell, electrode stabilizing agent, phosphazene derivative and method of producing the same
10/08/2009CA2720418A1 Pharmaceutical composition with bisphosphonate
1 ... 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 ... 554